Exosomes released into circulation possess the potential to provide insights into tumor status, as evidenced by the correlation between plasma exosomal microRNAs and the efficacy of immunotherapy in EGFR/ALK wild-type advanced NSCLC (Liu F. et al., 2024). Here, ALK is linked to non-small cell lung carcinoma.